Unexpectedly high prevalence of common variable immunodeficiency in Finland

Frontiers in Immunology

Volumn 8, Issue SEP, 2017, Pages

  Selenius, Jannica S ^a,b   Martelius, Timi ^b   Pikkarainen, Sampsa ^b   Siitonen, Sanna ^b   Mattila, Eero ^b   Pietikäinen, Risto ^c   Suomalainen, Pekka ^d   Aalto, Arja H ^d,e   Saarela, Janna ^b   Einarsdottir, Elisabet ^a,b,f   Järvinen, Asko ^b   Färkkilä, Martti ^b   Kere, Juha ^a,b,f,g   Seppänen, Mikko ^b  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^d SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f KAROLINSKA INSTITUTE   (Sweden)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Common variable immunodeficiency; Hypogammaglobulinemia; Prevalence; Primary antibody deficiency; Primary immunodeficiency; Secondary antibody deficiency

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PNEUMOCOCCUS VACCINE;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; COMMON VARIABLE IMMUNODEFICIENCY; CROSS-SECTIONAL STUDY; FEMALE; FINLAND; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; INFORMATION PROCESSING; LUNG CANCER; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; UTERINE CERVIX CANCER;

EID: 85030166282     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01190     Document Type: Article

References (33)

1. CEREDIH: The French PID Study Group. The French national registry of primary immunodeficiency diseases. Clin Immunol (2010) 135:264-72. doi:10.1016/j.clim.2010.02.021
2. Matamoros Florí N, Mila Llambi J, Español Boren T, Raga Borja S, Fontan Casariego G. Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J Clin Immunol (1997) 17:333-9. doi:10.1023/A:1027382916924
3. Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol (2000) 20:477-85. doi:10.1023/A:1026416017763
4. Kilic SS, Ozel M, Hafizoglu D, Karaca NE, Aksu G, Kutukculer N. The prevalences and patient characteristics of primary immunodeficiency diseases in Turkey-two centers study (2013). J Clin Immunol (2013) 33:74-83. doi:10.1007/s10875-012-9763-3
5. Edgar JDM, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al. The United Kingdom primary immune deficiency (UKPID) registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol (2014) 175:68-78. doi:10.1111/cei.12172
6. Marschall K, Hoernes M, Bitzenhofer-Gruber M, Jandus P, Duppenthaler A, Wuillemin WA, et al. The Swiss national registry for primary immunodeficiencies: report on the first 6 years' activity from 2008 to 2014. Clin Exp Immunol (2015) 182:45-50. doi:10.1111/cei.12661
7. Ludviksson BR, Sigurdardottir ST, Johannsson JH, Haraldsson A, Hardarson TO. Epidemiology of primary immunodeficiency in Iceland. J Clin Immunol (2015) 35:75-9. doi:10.1007/s10875-014-0107-3
8. Westh L, Mogensen TH, Dalgaard LS, Bernth Jensen JM, Katzenstein T, Hansen AE, et al. Identification and characterization of a nationwide Danish adult common variable immunodeficiency cohort. Scand J Immunol (2017) 85:450-61. doi:10.1111/sji.12551
9. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol (1999) 93:190-7. doi:10.1006/clim.1999.4799
10. European Society for Immunodeficiencies. New Clinical Diagnosis Criteria for the ESID Registry. (2017). Available from: https://esid.org/Working-Parties/Registry/Diagnosis-criteria
11. Ameratunga R, Brewerton M, Slade C, Jordan A, Gillis D, Steele R, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol (2014) 5:415. doi:10.3389/fimmu.2014.00415
12. Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract (2016) 4:38-59. doi:10.1016/j.jaip.2015.07.025
13. Borgers H, Moens L, Picard C, Jeurissen A, Raes M, Sauer K, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay. Clin Immunol (2010) 134:198-205. doi:10.1016/j.clim.2009.10.006
14. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol (2015) 136:1186-205.e1-78. doi:10.1016/j.jaci.2015.04.049
15. Beck SC. Making sense of serotype-specific pneumococcal antibody measurements. Ann Clin Biochem (2013) 50(Pt 6):517-9. doi:10.1177/0004563213500241
16. Kainulainen L, Nikoskelainen J, Ruuskanen O. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol (2001) 21:145-9. doi:10.1023/A:1011012023616
17. Chapel H, Lucas M, Patel S, Lee M, Cunningham-Rundles C, Resnick E, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol (2012) 130:1197-98.e9. doi:10.1016/j.jaci.2012.05.046
18. Seppänen M, Koillinen H, Mustjoki S, Tomi M, Sullivan KE. Terminal deletion of 11q with significant late-onset combined immune deficiency. J Clin Immunol (2014) 34:114-8. doi:10.1007/s10875-013-9966-2
19. Malphettes M, Gerard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis (2009) 49:1329-38. doi:10.1086/606059
20. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood (2008) 111:77-85. doi:10.1182/blood-2007-06-091744
21. Gathmann B, Mahlaoui N, Ceredih, Gerard L, Oksenhendler E, Warnatz K, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol (2014) 134:116-26. doi:10.1016/j.jaci.2013.12.1077
22. Kaustio M, Haapaniemi E, Göös H, Hautala T, Park G, Syrjänen J, et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol (2017) 140:782-96. doi:10.1016/j.jaci.2016.10.054
23. Schaballie H, Bosch B, Schrijvers R, Proesmans M, De Boeck K, Boon MN, et al. Fifth percentile cutoffvalues for antipneumococcal polysaccharide and anti-Salmonella typhi Vi IgG describe a normal polysaccharide response. Front Immunol (2017) 8:546. doi:10.3389/fimmu.2017.00546
24. Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol (2012) 130(Suppl 3):S1-24. doi:10.1016/j.jaci.2012.07.002
25. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood (2008) 112:277-86. doi:10.1182/blood-2007-11-124545
26. Salmela E, Lappalainen T, Fransson I, Andersen PM, Dahlman-Wright K, Fiebig A, et al. Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS One (2008) 3:e3519. doi:10.1371/journal.pone.0003519
27. Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, et al. Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency-association with neutropenia. Clin Exp Immunol (2006) 144:418-24. doi:10.1111/j.1365-2249.2006.03086.x
28. Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood (2014) 123:809-21. doi:10.1182/blood-2013-07-515528
29. Haapaniemi EM, Kaustio M, Rajala HL, van Adrichem AJ, Kainulainen L, GlumoffV, et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood (2015) 125:639-48. doi:10.1182/blood-2014-04-570101
30. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 536:285-91. doi:10.1038/nature19057
31. Trotta L, Hautala T, Hamalainen S, Syrjanen J, Viskari H, Almusa H, et al. Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland. Eur J Hum Genet (2016) 24:1473-8. doi:10.1038/ejhg.2016.37
32. Sajantila A, Salem AH, Savolainen P, Bauer K, Gierig C, Pääbo S. Paternal and maternal DNA lineages reveal a bottleneck in the founding of the Finnish population. Proc Natl Acad Sci U S A (1996) 93:12035-9. doi:10.1073/pnas.93.21.12035
33. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol (2010) 125:1354-60.e4. doi:10.1016/j.jaci.2010.02.040